All tariffs articles
-
OpinionExempt from the chaos? What Trump’s tariff carve-out means for architects working in UK life sciences
Michael Walters sets out how the Trump administration’s apparent tariff exemption for pharmaceuticals could offer a unique opportunity for the life sciences sector
-
OpinionTrump’s return: US architects brace for challenges over the next four years
From the possible return of neoclassical mandates to a threatened clampdown on immigration, Chris Fogarty assesses the potential impact of a second Trump presidency on US architecture